DP1-S

DP1-S

5mg / Single Vial
$69.00
Sale price  $69.00 Regular price 
Skip to product information
DP1-S

DP1-S

$69.00
Sale price  $69.00 Regular price 
Size
Quantity

Research Use Only

All products are intended solely for laboratory research and are not for human or animal consumption. By purchasing, the buyer agrees to use these products in compliance with all applicable laws.

DP1-S Overview

DP1-S is a synthetic peptide analog that is structurally modified for extended pathway activity. It is studied in preclinical laboratory models for its ability to activate target pathways and modulate downstream molecular signaling associated with endocrine regulation.

Marso S.P. et al. (2016).

History

Research into endocrine peptide biology began in the 1980s with the identification of key peptide roles in signaling pathways. Early synthetic agonists demonstrated promise in extending pathway activation, but limited half-life restricted their utility. DP1-S was later developed with structural modifications at specific amino acid positions to improve target binding and extend duration of action, making it a useful tool for studying peptide biology and downstream signaling in preclinical research models.

Knudsen L.B. et al. (2000).

DP1-S Structure



Molecular Formula: C₁₈₇H₂₉₁N₄₅O₅₉
Molecular Weight: 4113.6 g/mol
PubChem ID: 56843331

Research Findings

DP1-S has been studied across multiple biological models, with research highlighting its activity in downstream pathway signaling and molecular response dynamics in laboratory settings.

Key Areas of Research:

  • Signaling: Pathway dynamics, downstream cascades

  • Endocrine: Target pathway modulation

  • Systemic: Lipid pathways, signaling markers

Together, these findings suggest broad experimental potential for DP1-S across multiple biological pathways. By engaging target pathways and influencing downstream molecular signaling, DP1-S provides a versatile platform for investigating pathway-mediated responses and systemic characterization in preclinical laboratory settings.

Wilding J.P.H. et al., 2021

You may also like